| Serial Number | 90726719 |
| Word Mark | MYOLIVITY |
| Filing Date | Friday, May 21, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, March 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products, namely, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| Pseudo Mark | MY OLIVETTI |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 18, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Friday, March 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 28, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, March 28, 2024 | SOU EXTENSION 3 FILED |
| Thursday, March 28, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 10, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 10, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, October 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 28, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, March 28, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, March 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 3, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 3, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, February 3, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 2, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, August 18, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 25, 2021 | NEW APPLICATION ENTERED |